Skip to main content
. 2010 Jul 24;66(11):1143–1150. doi: 10.1007/s00228-010-0865-7

Table 4.

Opinions on reporting ADRs

Opinions Strongly agree Agree Neutral Disagree Strongly disagree
Reporting an adverse drug reaction can prevent harm to other people 61.1% (610) 32.7% (327) 4.1% (41) 1.6% (16) 0.5% (5)
I felt responsible for reporting an adverse drug reaction 50.5% (504) 40.2% (402) 8.1% (81) 1.0% (10) 0.2% (2)
Reporting an adverse drug reaction that is already mentioned in the patient information leaflet is useless 13.9% (139) 20.1% (201) 18.8% (188) 31.7% (317) 15.4% (154)
I only report an adverse drug reaction if it is serious 24.6% (246) 34.5% (345) 14.9% (149) 20.5% (205) 5.4% (54)
Reporting an adverse drug reaction contributes to research and knowledge 60.9% (608) 37.0% (370) 1.8% (18) 0 0.3% (3)
I report an adverse drug reaction if it is not mentioned in the patient information leaflet 39.5% (395) 35.2% (352) 14.8% (148) 8.7% (87) 1.7% (17)
I benefit from reporting an adverse drug reaction 11.7% (117) 23.3% (233) 36.2% (362) 19.8% (198) 8.9% (89)
Reporting an adverse drug reaction contributes to improvement of drugs 41.4% (414) 43.7% (437) 13.2% (132) 1.2% (12) 0.4% (4)
I report an adverse drug reaction if it is unexpected 30.2% (302) 41.1% (411) 17.0% (170) 9.0% (90) 2.6% (26)
In the future I will report a possible adverse drug reaction once again 47.9% (479) 44.4% (444) 6.7% (67) 0.3% (3) 0.6% (6)

Data on motives are given as the percentage of total responses, with the frequency (n) of the response given in parenthesis

Most frequently reported response is given in bold